Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vical Inc (NASDAQ:VICL)

2.66
Delayed Data
As of Jul 21
 +0.0099 / +0.37%
Today’s Change
2.05
Today|||52-Week Range
4.50
+15.65%
Year-to-Date
No recent news for Vical Inc.

Today’s Trading

Previous close2.65
Today’s open2.57
Day’s range2.56 - 2.73
Volume40,127
Average volume (3 months)88,056
Market cap$29.5M
Dividend yield--
Data as of 3:59pm ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)+10.00%
Earnings growth (this year)-13.89%
Earnings growth (next 5 years)--
Revenue growth (last year)-30.64%
P/E ratioNM
Price/Sales1.59
Price/Book0.65

Competitors

 Today’s
change
Today’s
% change
CAPRCapricor Therapeutic...+0.04+3.15%
CBLICleveland Biolabs In...-0.15-5.40%
--Soleno Therapeutics ...+0.00+0.42%
XBIOXenetic Biosciences ...+0.30+10.17%
Data as of 4:00pm ET, 07/21/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$14.5M
Annual profit (last year)-$9.0M
Net profit margin-61.75%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Vijay B. Samant
Vice President-
Operations
Keith D. Hall
Corporate headquarters
San Diego, California

Forecasts